THE PHARM BIO
LIVE

Serial Number

79334653

Owner

The Pharm Bio Pty Ltd as trustee for The

Filing Date

Sep 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

THE PHARM BIO Trademark

Serial Number: 79334653 • Registration: 7095416

THE PHARM BIO is a trademark filed by The Pharm Bio Pty Ltd as trustee for The on September 10, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

The Pharm Bio Pty Ltd as trustee for The (2 trademarks)

Bio21 Institute,
Parkville VIC 3052 , AU

Entity Type: 99

The Pharm Bio Pty Ltd as trustee for ThePharm Bio Unit Trust (2 trademarks)

Bio21 Institute,
Parkville VIC 3052 , AU

Entity Type: 99

SYNthesis Research Pty Ltd

Bio21 Institute,

Entity Type: 82

Trademark Details

Filing Date

September 10, 2021

Registration Date

July 4, 2023

Published for Opposition

April 11, 2023

Goods & Services

Financial services, namely, capital investment; funds management, namely, management of a capital investment fund; venture capital financing; venture capital fund management; investment services, namely, asset acquisition for financial investment; investment of funds for others; commercial property investment services, namely, investment of funds for others in the field of commercial property; capital investment in real estate; trustee services, namely, investment trusteeship; trust investment services, namely, investment and trust company services; investment management; financial investment custody services, namely, maintaining possession of financial assets for others for financial management purposes; financial portfolio management; financial investment fund services, namely, investment of funds for others; trading in stocks; advancement of funds, namely, cash advance services for businesses and merchants; capital investment; financial services, namely, commodity trading for others; financial services, namely, investment asset management; financial services, namely, financial portfolio management; project financing; financing services; financial advisory services; financial consultancy; financial information services; investment advice; financial analysis, namely, investment analysis; providing investment information; financial research, namely, investment research; provision and funding of educational scholarships; advisory and consultancy services relating to the aforementioned services

Medical advisory services relating to pharmaceutical products; pharmaceutical advisory services; provision of medical information relating to pharmaceuticals; consultancy and advisory services in relation to medical services; consultancy relating to health care; health care consultancy services, namely, consultancy services in the field of medical care

Licensing of intellectual property rights; legal services related to the exploitation of intellectual property rights; enforcement of intellectual property rights by means of submitting copyright takedown notices for others; advisory services relating to intellectual property rights; legal research relating to intellectual property

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 12, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Oct 5, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 5, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
ELECTRONIC RECORD REVIEW COMPLETE
May 30, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 26, 2023 ERRR
NOTIFICATION PROCESSED BY IB
Apr 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 5, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
CHANGE OF OWNER RECEIVED FROM IB
Mar 18, 2023 CHLD
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 8, 2023 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2022 RFNP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2022 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 29, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 7, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 6, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 2, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 14, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2022 REPR